Geron cancer drug highly effective in trial, shares soar - Reuters

[INCIID News Feed]

<img alt="" height="1" width="1" />
Geron cancer drug highly effective in trial, shares soar
Reuters
Thu Nov 7, 2013 9:57am EST. (Reuters) - Geron Corp said 22 percent of patients treated by its experimental blood cancer drug in a clinical trial were free of the disease, and its shares more than doubled in value in early trading. The company also said that ...
Geron Doubles as Imetelstat Helps Against Bone Marrow DisorderBusinessweek
Geron shares soar on promising imetelstat data for myelofibrosisFierceBiotech

all 5 news articles &raquo;


More...